The use of weighted and scored risk assessment models for venous thromboembolism

Thrombosis and Haemostasis

Volumn 108, Issue 6, 2012, Pages 1072-1076

  Spyropoulos, Alex C ^a   McGinn, Thomas ^b   Khorana, Alok A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Northwell Health   (United States)

Author keywords

Epidemiological studies; Risk factors; Venous thrombosis

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

AGE; ARTICLE; BLOOD CELL COUNT; BODY MASS; DISEASE CLASSIFICATION; HORMONAL THERAPY; HUMAN; IMMOBILIZATION; NEOPLASM; PARALYSIS; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; THROMBOPHILIA; VALIDATION PROCESS; VENOUS THROMBOEMBOLISM;

FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; MODELS, CARDIOVASCULAR; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84870889254     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-07-0508     Document Type: Article

References (19)

1. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e227S-277S.
2. Spyropoulos AC. Risk assessment of venous thromboembolism in hospitalized medical patients. Curr Opin Pulm Med 2010; 16: 419-425.
3. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004; 164: 963-968.
4. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Hae-most 2005; 94: 750-759.
5. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111: 4902-4907.
6. Royston P, Moons KG, Altman DG, et al. Prognosis and prognostic research: Developing a prognostic model. Br Med J 2009; 338: b604.
7. Mandala M, Barni S, Floriani I, et al. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alter-nating schedule' study findings. Eur J Cancer 2009; 45: 65-73.
8. Spyropoulos AC. Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients. J Thromb Haemost 2009; 7: 1041-1042.
9. McGinn TG, Guyatt GH, Wyer PC, et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. J Am Med Assoc 2000; 284: 79-84.
10. Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010; 251: 344-350.
11. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285: 2864-2870.
12. Wu O, Bayoumi N, Vickers MA, et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-69.
13. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. Br Med J 1992; 305: 567-574.
14. Clagett G P, Anderson FA, Jr., Geerts W, et al. Prevention of venous thromboem-bolism. Chest 1998; 114 (5 Suppl): 531S-560S.
15. Turpie AG, Chin BS, Lip GY. ABC of antithrombotic therapy: Venous throm-boembolism: treatment strategies. Br Med J 2002; 325: 948-950.
16. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983; 74: 1023-1028.
17. Laffan M, Tuddenham E. Science, medicine, and the future: assessing thrombotic risk. Br Med J 1998; 317: 520-523.
18. Spyropoulos AC, Anderson FA, Jr., Fitzgerald G, et al. Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE. Chest 2011; 140: 706-714.
19. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboem-bolism among hospitalized patients. N Engl J Med 2005; 352: 969-977.